Information
    Formula C8H13N5O3 Count 510
In stock

methyl 2-[5-(morpholin-4-yl)-2H-1,2,3,4-tetrazol-2-yl]acetate

Compound number
MolPort-000-144-414
SMILES
COC(=O)Cn1nnc(n1)N1CCOCC1
Molecular formula
C8H13N5O3
Molecular weight
227.22
In stock

2-(5-methyl-3-nitro-1H-pyrazol-1-yl)butanehydrazide

Compound number
MolPort-000-161-576
SMILES
CCC(C(=O)NN)n1nc(cc1C)[N+]([O-])=O
Molecular formula
C8H13N5O3
Molecular weight
227.22
In stock

2-methyl-3-(5-methyl-3-nitro-1H-pyrazol-1-yl)propanehydrazide

Compound number
MolPort-000-161-591
SMILES
CC(Cn1nc(cc1C)[N+]([O-])=O)C(=O)NN
Molecular formula
C8H13N5O3
Molecular weight
227.22
In stock

2-(3,5-dimethyl-4-nitro-1H-pyrazol-1-yl)propanehydrazide

Compound number
MolPort-000-161-667
SMILES
CC(C(=O)NN)n1nc(C)c(c1C)[N+]([O-])=O
Molecular formula
C8H13N5O3
Molecular weight
227.22
In stock

3-(3,5-dimethyl-4-nitro-1H-pyrazol-1-yl)propanehydrazide

Compound number
MolPort-000-161-749
SMILES
Cc1nn(CCC(=O)NN)c(C)c1[N+]([O-])=O
Molecular formula
C8H13N5O3
Molecular weight
227.22
In stock

N-(2-aminoethyl)-1-ethyl-4-nitro-1H-pyrazole-5-carboxamide

Compound number
MolPort-000-891-197
SMILES
CCn1ncc(c1C(=O)NCCN)[N+]([O-])=O
Molecular formula
C8H13N5O3
Molecular weight
227.22
Discontinued

N-(2-aminoethyl)-1-ethyl-4-nitro-1H-pyrazole-3-carboxamide

Compound number
MolPort-000-891-205
SMILES
CCn1cc(c(n1)C(=O)NCCN)[N+]([O-])=O
Molecular formula
C8H13N5O3
Molecular weight
227.22
Discontinued

N-(2-aminoethyl)-2-(3-methyl-4-nitro-1H-pyrazol-1-yl)acetamide

Compound number
MolPort-000-891-213
SMILES
Cc1nn(CC(=O)NCCN)cc1[N+]([O-])=O
Molecular formula
C8H13N5O3
Molecular weight
227.22
Discontinued

N-(2-aminoethyl)-2-(5-methyl-4-nitro-1H-pyrazol-1-yl)acetamide

Compound number
MolPort-000-891-216
SMILES
Cc1c(cnn1CC(=O)NCCN)[N+]([O-])=O
Molecular formula
C8H13N5O3
Molecular weight
227.22
Discontinued

N-(2-aminoethyl)-2-(5-methyl-3-nitro-1H-pyrazol-1-yl)acetamide

Compound number
MolPort-000-891-220
SMILES
Cc1cc(nn1CC(=O)NCCN)[N+]([O-])=O
Molecular formula
C8H13N5O3
Molecular weight
227.22
Discontinued

N-(2-aminoethyl)-3-(3-nitro-1H-pyrazol-1-yl)propanamide

Compound number
MolPort-000-891-521
SMILES
NCCNC(=O)CCn1ccc(n1)[N+]([O-])=O
Molecular formula
C8H13N5O3
Molecular weight
227.22
Discontinued

N-(2-aminoethyl)-3-(4-nitro-1H-pyrazol-1-yl)propanamide

Compound number
MolPort-000-891-522
SMILES
NCCNC(=O)CCn1cc(cn1)[N+]([O-])=O
Molecular formula
C8H13N5O3
Molecular weight
227.22
Discontinued

N-(3-aminopropyl)-2-(3-nitro-1H-pyrazol-1-yl)acetamide

Compound number
MolPort-000-891-565
SMILES
NCCCNC(=O)Cn1ccc(n1)[N+]([O-])=O
Molecular formula
C8H13N5O3
Molecular weight
227.22
Discontinued

N-(3-aminopropyl)-2-(4-nitro-1H-pyrazol-1-yl)acetamide

Compound number
MolPort-000-891-567
SMILES
NCCCNC(=O)Cn1cc(cn1)[N+]([O-])=O
Molecular formula
C8H13N5O3
Molecular weight
227.22
In stock

N-butyl-2-(3-nitro-1H-1,2,4-triazol-1-yl)acetamide

Compound number
MolPort-001-493-652
SMILES
CCCCNC(=O)Cn1cnc(n1)[N+]([O-])=O
Molecular formula
C8H13N5O3
Molecular weight
227.22
In stock

N-tert-butyl-2-(3-nitro-1H-1,2,4-triazol-1-yl)acetamide

Compound number
MolPort-001-623-090
SMILES
CC(C)(C)NC(=O)Cn1cnc(n1)[N+]([O-])=O
Molecular formula
C8H13N5O3
Molecular weight
227.22
In stock

2-[(6-amino-5-nitropyrimidin-4-yl)amino]butan-1-ol

Compound number
MolPort-001-839-286
SMILES
CCC(CO)Nc1ncnc(N)c1[N+]([O-])=O
Molecular formula
C8H13N5O3
Molecular weight
227.22
Discontinued

2-amino-9-[(2-hydroxyethoxy)methyl]-4,5,6,9-tetrahydro-1H-purin-6-one

Compound number
MolPort-002-042-377
SMILES
NC1=NC2C(N=CN2COCCO)C(=O)N1 |c:5,t:1|
Molecular formula
C8H13N5O3
Molecular weight
227.22
In stock

N4-(1-methoxypropan-2-yl)-5-nitropyrimidine-4,6-diamine

Compound number
MolPort-002-274-522
SMILES
COCC(C)Nc1ncnc(N)c1[N+]([O-])=O
Molecular formula
C8H13N5O3
Molecular weight
227.22
In stock

N4-(3-methoxypropyl)-5-nitropyrimidine-4,6-diamine

Compound number
MolPort-002-274-873
SMILES
COCCCNc1ncnc(N)c1[N+]([O-])=O
Molecular formula
C8H13N5O3
Molecular weight
227.22

We use cookies to improve your experience on our websites and for advertising. By clicking "Accept All", you consent to our use of cookies. Learn more.

Feedback